Literature DB >> 8864381

Taxol-induced acral erythema.

D de Argila1, J D Dominguez, L Iglesias.   

Abstract

Chemotherapy-induced acral erythema is a peculiar localized cutaneous response to several chemotherapeutic agents, mostly antimetabolites. Taxol is a recently developed antineoplastic drug that acts on the mitotic spindle and does not interfere with nucleic acid synthesis. We describe the first case of taxol-induced acral erythema and report on additional data concerning the pathogenesis of this kind of toxic eruptions.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8864381     DOI： 10.1159/000246419

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  4 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Management of Paclitaxel-induced hand-foot syndrome.

Authors:  Hussein A Assi; Zeina A Ayoub; Sara M Jaber; Hassan A Sibai; Nagi S El Saghir
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

3.  Fingerprint changes among cancer patients treated with paclitaxel.

Authors:  Payam Azadeh; Simin Dashti-Khavidaki; Ali Yaghobi Joybari; Samaneh Sarbaz; Atefeh Jafari; Mehdi Yaseri; Afshin Amini; Maryam Farasatinasab
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-17       Impact factor: 4.553

4.  Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.

Authors:  Pia Vihinen; Outi Paija; Atte Kivisaari; Leena Koulu; Heikki Aho
Journal:  J Med Case Rep       Date:  2011-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.